Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Peptide Therapeutics can be widely used to treat cancer, metabolic disorders, and cardiovascular diseases. When the level of endogenous peptide tends to decline, peptide drugs will be used as an alternative therapy to supplement peptide hormones. Clinical global authorities in the United States, Europe and Japan have approved 60 peptide drugs.
During the forecast period, the Peptide Therapeutics market will achieve significant market growth, culminating in a compound annual growth rate of 8.4%. Cell-penetrating peptides will bring a broader prospect for the Peptide Therapeutics market. Cell-penetrating peptides, known as ideal transporters, assist therapeutic drugs in a nontoxic and simple manner, including proteins, oligonucleotides, nanoparticles, and so on.
The increase in the incidence rate of cancer and metabolic diseases such as osteoporosis, obesity and diabetes is a major factor driving the growth of Peptide Therapeutics market during the forecast period. In addition, the growing population base affected and the prevalence of targeted diseases in low-income countries will greatly stimulate the market demand for Peptide Therapeutics.
This report elaborates on the current development of the Peptide Therapeutics industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Ferring
Allergan
J & J
Takeda
Novo Nordisk
Sanofi
Teva
AstraZeneca
AbbVie
The Medicines
Eli Lilly
Merck
Novartis
Shire
Ipsen
Roche
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Injection
Oral
Other
Application:
Cancer
Metabolic Disorders
Central Nervous System
Cardiovascular Disorder
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Peptide Therapeutics Industry Overview
-
1.1.1 Peptide Therapeutics Market Scope and Market Segments
-
1.1.2 Peptide Therapeutics Industry Characteristics
-
1.1.3 Global and China Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Peptide Therapeutics Production Value and Growth Rate (2017-2028)
-
1.2 Global Peptide Therapeutics Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Injection
-
1.2.2 Oral
-
1.2.3 Other
-
1.3 Global Peptide Therapeutics Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Cancer
-
1.3.2 Metabolic Disorders
-
1.3.3 Central Nervous System
-
1.3.4 Cardiovascular Disorder
-
1.3.5 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America Peptide Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Peptide Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Peptide Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Peptide Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Peptide Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Peptide Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Peptide Therapeutics Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Peptide Therapeutics Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Peptide Therapeutics Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Peptide Therapeutics Industry Porter's Five Forces Model Analysis
-
2.2.3 Peptide Therapeutics Industry PEST Analysis
-
2.3 Peptide Therapeutics Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Peptide Therapeutics Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Peptide Therapeutics Industry
Chapter 3 Global and China Peptide Therapeutics Market, by Manufacturer
-
3.1 Global and China Peptide Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Peptide Therapeutics Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Peptide Therapeutics Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Peptide Therapeutics Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Peptide Therapeutics Market Top 3 Players
Chapter 4 Global and China Peptide Therapeutics Market, by Type (2017-2028)
-
4.1 Peptide Therapeutics Market Trend, by Type
-
4.2 Global Peptide Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Peptide Therapeutics Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Peptide Therapeutics Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Peptide Therapeutics Price Trend, by Type (2017-2028)
-
4.3 China Peptide Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Peptide Therapeutics Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Peptide Therapeutics Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Peptide Therapeutics Price Trend, by Type (2017-2028)
Chapter 5 Global and China Peptide Therapeutics Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Peptide Therapeutics Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Peptide Therapeutics Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Peptide Therapeutics Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Peptide Therapeutics Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Peptide Therapeutics Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Peptide Therapeutics Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Peptide Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Peptide Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Peptide Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Peptide Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Peptide Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Peptide Therapeutics Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Peptide Therapeutics Market Analysis
-
7.1 North America Peptide Therapeutics Market, by Type
-
7.2 North America Peptide Therapeutics Market, by Application
-
7.3 North America Peptide Therapeutics Market Analysis and Forecast, by Country
-
7.3.1 United States Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Peptide Therapeutics Market Analysis
-
8.1 Europe Peptide Therapeutics Market, by Type
-
8.2 Europe Peptide Therapeutics Market, by Application
-
8.3 Europe Peptide Therapeutics Market Analysis and Forecast, by Country
-
8.3.1 Germany Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Peptide Therapeutics Market Analysis
-
9.1 APAC Peptide Therapeutics Market, by Type
-
9.2 APAC Peptide Therapeutics Market, by Application
-
9.3 APAC Peptide Therapeutics Market Analysis and Forecast, by Country
-
9.3.1 China Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Peptide Therapeutics Market Analysis
-
10.1 Latin America, Middle East and Africa Peptide Therapeutics Market, by Type
-
10.2 Latin America, Middle East and Africa Peptide Therapeutics Market, by Application
-
10.3 Latin America, Middle East and Africa Peptide Therapeutics Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Peptide Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Peptide Therapeutics Company Profiles
-
11.1 Ferring
-
11.1.1 Ferring Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Ferring Peptide Therapeutics Product Profiles, Application and Specification
-
11.1.3 Ferring Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Allergan
-
11.2.1 Allergan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Allergan Peptide Therapeutics Product Profiles, Application and Specification
-
11.2.3 Allergan Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 J & J
-
11.3.1 J & J Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 J & J Peptide Therapeutics Product Profiles, Application and Specification
-
11.3.3 J & J Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Takeda
-
11.4.1 Takeda Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Takeda Peptide Therapeutics Product Profiles, Application and Specification
-
11.4.3 Takeda Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Novo Nordisk
-
11.5.1 Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Novo Nordisk Peptide Therapeutics Product Profiles, Application and Specification
-
11.5.3 Novo Nordisk Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Sanofi
-
11.6.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Sanofi Peptide Therapeutics Product Profiles, Application and Specification
-
11.6.3 Sanofi Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Teva
-
11.7.1 Teva Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Teva Peptide Therapeutics Product Profiles, Application and Specification
-
11.7.3 Teva Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 AstraZeneca
-
11.8.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 AstraZeneca Peptide Therapeutics Product Profiles, Application and Specification
-
11.8.3 AstraZeneca Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 AbbVie
-
11.9.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 AbbVie Peptide Therapeutics Product Profiles, Application and Specification
-
11.9.3 AbbVie Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 The Medicines
-
11.10.1 The Medicines Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 The Medicines Peptide Therapeutics Product Profiles, Application and Specification
-
11.10.3 The Medicines Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Eli Lilly
-
11.11.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Eli Lilly Peptide Therapeutics Product Profiles, Application and Specification
-
11.11.3 Eli Lilly Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Merck
-
11.12.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Merck Peptide Therapeutics Product Profiles, Application and Specification
-
11.12.3 Merck Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Novartis
-
11.13.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Novartis Peptide Therapeutics Product Profiles, Application and Specification
-
11.13.3 Novartis Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Shire
-
11.14.1 Shire Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Shire Peptide Therapeutics Product Profiles, Application and Specification
-
11.14.3 Shire Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.15 Ipsen
-
11.15.1 Ipsen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.15.2 Ipsen Peptide Therapeutics Product Profiles, Application and Specification
-
11.15.3 Ipsen Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.16 Roche
-
11.16.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.16.2 Roche Peptide Therapeutics Product Profiles, Application and Specification
-
11.16.3 Roche Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Peptide Therapeutics Industry Investment Prospect and Risk Assessment
-
12.1 Peptide Therapeutics Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Peptide Therapeutics Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure China Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Global Peptide Therapeutics Production Value and Growth Rate (2017-2028)
-
Figure China Peptide Therapeutics Production Value and Growth Rate (2017-2028)
-
Figure Global Peptide Therapeutics Market Size and Growth Rate of Injection (2017-2028)
-
Figure Global Peptide Therapeutics Market Size and Growth Rate of Oral (2017-2028)
-
Figure Global Peptide Therapeutics Market Size and Growth Rate of Other (2017-2028)
-
Figure Global Peptide Therapeutics Market Size and Growth Rate of Cancer (2017-2028)
-
Figure Global Peptide Therapeutics Market Size and Growth Rate of Metabolic Disorders (2017-2028)
-
Figure Global Peptide Therapeutics Market Size and Growth Rate of Central Nervous System (2017-2028)
-
Figure Global Peptide Therapeutics Market Size and Growth Rate of Cardiovascular Disorder (2017-2028)
-
Figure Global Peptide Therapeutics Market Size and Growth Rate of Others (2017-2028)
-
Figure North America Peptide Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Peptide Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Peptide Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Peptide Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Peptide Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Peptide Therapeutics Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Peptide Therapeutics Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Peptide Therapeutics Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Peptide Therapeutics Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Peptide Therapeutics Market Share, by Manufacturer in 2021
-
Figure Global and China Peptide Therapeutics Market Share, by Manufacturer in 2022
-
Table Global Peptide Therapeutics Sales Volume, by Type (2017-2028)
-
Table Global Peptide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure Global Peptide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table Global Peptide Therapeutics Sales Value, by Type (2017-2028)
-
Table Global Peptide Therapeutics Sales Value Share, by Type (2017-2028)
-
Figure Global Peptide Therapeutics Price Trend, by Type (2017-2028)
-
Table China Peptide Therapeutics Sales Volume, by Type (2017-2028)
-
Table China Peptide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure China Peptide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table China Peptide Therapeutics Sales Value, by Type (2017-2028)
-
Table China Peptide Therapeutics Sales Value Share, by Type (2017-2028)
-
Figure China Peptide Therapeutics Price Trend, by Type (2017-2028)
-
Table Global Peptide Therapeutics Sales Volume, by Application (2017-2028)
-
Table Global Peptide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Global Peptide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Table Global Peptide Therapeutics Sales Value, by Application (2017-2028)
-
Table Global Peptide Therapeutics Sales Value Share, by Application (2017-2028)
-
Figure Global Peptide Therapeutics Sales Value Share, by Application (2017-2028)
-
Table China Peptide Therapeutics Sales Volume, by Application (2017-2028)
-
Table China Peptide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure China Peptide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Table China Peptide Therapeutics Sales Value, by Application (2017-2028)
-
Table China Peptide Therapeutics Sales Value Share, by Application (2017-2028)
-
Figure China Peptide Therapeutics Sales Value Share, by Application (2017-2028)
-
Figure China Peptide Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure North America Peptide Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Peptide Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Peptide Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Peptide Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Table North America Peptide Therapeutics Sales Volume, by Type (2017-2028)
-
Table North America Peptide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure North America Peptide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table North America Peptide Therapeutics Sales Volume, by Application (2017-2028)
-
Table North America Peptide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure North America Peptide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure United States Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure United States Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Canada Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table Europe Peptide Therapeutics Sales Volume, by Type (2017-2028)
-
Table Europe Peptide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure Europe Peptide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table Europe Peptide Therapeutics Sales Volume, by Application (2017-2028)
-
Table Europe Peptide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Europe Peptide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Germany Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure UK Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure UK Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure France Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure France Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Italy Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Spain Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Poland Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Russia Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table APAC Peptide Therapeutics Sales Volume, by Type (2017-2028)
-
Table APAC Peptide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure APAC Peptide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table APAC Peptide Therapeutics Sales Volume, by Application (2017-2028)
-
Table APAC Peptide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure APAC Peptide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure China Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure China Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Japan Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure India Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure India Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Peptide Therapeutics Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Peptide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Peptide Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Peptide Therapeutics Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Peptide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Peptide Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Peptide Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Peptide Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table Ferring Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ferring Product Profiles, Application and Specification
-
Table Ferring Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Allergan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Allergan Product Profiles, Application and Specification
-
Table Allergan Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table J & J Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table J & J Product Profiles, Application and Specification
-
Table J & J Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Takeda Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Takeda Product Profiles, Application and Specification
-
Table Takeda Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novo Nordisk Product Profiles, Application and Specification
-
Table Novo Nordisk Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Teva Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Teva Product Profiles, Application and Specification
-
Table Teva Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AstraZeneca Product Profiles, Application and Specification
-
Table AstraZeneca Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AbbVie Product Profiles, Application and Specification
-
Table AbbVie Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table The Medicines Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table The Medicines Product Profiles, Application and Specification
-
Table The Medicines Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eli Lilly Product Profiles, Application and Specification
-
Table Eli Lilly Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck Product Profiles, Application and Specification
-
Table Merck Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Shire Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Shire Product Profiles, Application and Specification
-
Table Shire Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ipsen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ipsen Product Profiles, Application and Specification
-
Table Ipsen Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Roche Product Profiles, Application and Specification
-
Table Roche Peptide Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
